It is a myth that cancer is prevalent only in urban areas More than 5,56,000 cancer deaths occurred in India in 2010 and 71.1 per cent of those who died were aged between 30 and 69 years, says a report on cancer mortality in India, published in the March 28 issue of The Lancet. While men in the age group of 30-69 years are more likely to die of oral cancers followed...
More »SEARCH RESULT
A bound-to-fail positive effort-Panini Anand
THE DEBATE on the National Food Security Bill, tabled in parliament three months ago, is on full swing. Economists from both sides are arming their arguments with facts and logic. The people who would benefit of this legislation are in a dilemma. This prompts the consideration that the experts must try to see the issue from the ground reality of food security and its beneficiaries. Undoubtedly, it’s a great and historical...
More »UN-backed effort aims to vaccinate 111 million children against polio in four days
-The United Nations A United Nations-backed campaign will seek to vaccinate more than 111 million children under the age of five against polio in 20 African countries in just four days. “The upcoming campaign in West and Central Africa will aim to cover all children, immunized or not, in order to boost their protection levels and deprive the virus of the fertile seedbed on which it depends for survival,” said the World...
More »Cheap generics no panacea for India's poorest
-Reuters Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumour. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai's biggest cancer hospital. "What is a generic drug?" shrugs Nissar, who has travelled over 1,500 kms (900 miles) from his home in the hope of treatment. "I have borrowed money from friends and relatives...
More »Natco gets India’s first compulsory licence-CH Unnikrishnan
In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...
More »